Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC [Phase 2]
The document reports the completion of a Phase 2 clinical trial comparing BMS-690514 with erlotinib in patients with previously treated non-…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response [Phase 2]
Phase 2 trial of BMS-690514 in non-small cell lung cancer patients who are EGFR mutation positive or had prior response to gefitinib/erlotin…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer [Phase 2]
Phase II trial of a novel anti-angiogenic agent in combination with chemotherapy for non-small cell lung cancer; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types [Phase 2]
Phase II clinical trial of Brivanib (BMS-582664) across multiple tumor types has completed.
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating enzastaurin with carboplatin and gemcitabine, with or without bevacizumab, for recurrent stage IIIB or IV non-sma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-10-08Clinical Trial Update: Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated neoadjuvant chemoradiotherapy with or without gefitinib in patients with Stage IIIA or IIIB non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) in combination with gemcitabine, with or without cisplatin, as first-line treatment in elderl…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib [Phase 1]
Phase 1 trial evaluating continuous once-daily oral afatinib (BIBW 2992) plus sirolimus (Rapamune) in patients with non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating pioglitazone hydrochloride in patients with stage I-IIIA non-small cell lung cancer was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection [Phase 1]
Phase 1 trial evaluating erlotinib hydrochloride for HIV-infected patients with metastatic or unresectable non-small cell lung cancer was te…
-
CLINICAL_TRIALS research · 2015-10-06Clinical Trial Update: Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level
A clinical trial evaluating surgical resection with adjuvant therapy for stage IIIA non-small cell lung cancer with N2 disease limited to su…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients. [Phase 2]
This Phase 2 study in the UK evaluated the incidence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]
This document reports a Phase 1 trial evaluating celecoxib in patients with stage IIIB or stage IV non-small cell lung cancer. The trial sta…
-
CLINICAL_TRIALS withdrawal · 2015-10-02Clinical Trial Update: Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial of vandetanib (ZD6474) combined with fulvestrant (Faslodex) in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [Phase 1]
Phase 1 study evaluating the combination of erlotinib hydrochloride and cetuximab in patients with advanced cancers including head and neck,…
-
CLINICAL_TRIALS withdrawal · 2015-09-30Clinical Trial Update: Time Trends in Waiting Times of NSCLC Patients.
A clinical trial evaluating the time trends in waiting times for non-small cell lung cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating RO4929097 with erlotinib hydrochloride in stage IV or recurrent non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Cabazitaxel in Relapsed and Metastatic NSCLC [Phase 2]
This Phase 2 clinical trial update reports completion of a cabazitaxel study in relapsed and metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib with gemcitabine and cisplatin in advanced or metastatic non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC [Phase 2]
A Phase 2 trial of docetaxel plus bevacizumab in elderly patients with stage IV non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib in combination with bevacizumab as second-line therapy for non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing first-line Bevacizumab (Avastin) plus Erlotinib for stage IIIB/IV or recurrent non-squamous non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial of a decitabine-genistein combination reports maximum tolerated dose determination and early signals of safety and efficacy …
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: DNA Chip Based Prognosis of Lung Cancer
Completed clinical trial evaluating a DNA chip-based prognosis method for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating surgery with gemcitabine, cisplatin, and radiation for stage II or III non-small cell lung cancer was terminated,…